Skip Navigation

Cardiovascular Research 2005 65(2):495-504; doi:10.1016/j.cardiores.2004.10.026
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ellmark, S. H.M.
Right arrow Articles by Drummond, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellmark, S. H.M.
Right arrow Articles by Drummond, G. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle

Sara H.M. Ellmark, Gregory J. Dusting*, Mark Ng Tang Fui, Nancy Guzzo-Pernell and Grant R. Drummond1

Howard Florey Institute, University of Melbourne, Victoria 3010, Australia

* Corresponding author. Tel.: +61 3 8344 1961; fax: +61 3 9348 1707. Email address: g.dusting{at}hfi.unimelb.edu.au Grant.Drummond{at}med.monash.edu.au

Objective: NADPH oxidases are important sources of reactive oxygen species (ROS) in the vasculature. In phagocytic cells, the catalytic subunit of NADPH oxidase is a glycoprotein, gp91phox. However, vascular smooth muscle cells (VSMCs), which show prominent NADPH oxidase activity, lack gp91phox. Hence, we examined the role of Nox4, a gp91phox homologue, in superoxide production in mouse-cultured VSMCs.

Methods and results: Incubation of VSMCs with NADPH increased ROS production whether detected by lucigenin-enhanced chemiluminescence or dichlorofluorescein. Superoxide production was inhibited by the NADPH oxidase inhibitors, diphenyleneiodonium and apocynin, but not by inhibitors of other potential sources of superoxide. In unstimulated VSMCs, phosphorothioate antisense oligonucleotides against Nox4 down-regulated mRNA expression of the subunit by 65% and attenuated superoxide production by 41% without affecting Nox1 expression. Interleukin-1β (IL-β) thrombin and platelet-derived growth factor (PDGF) also reduced Nox4 mRNA expression after 3 h without affecting Nox1 levels. Of these stimuli, only IL-β reduced superoxide, but this effect was more rapid (≥ 30 min) than its actions on Nox4.

Conclusions: Under resting conditions, NADPH oxidase activity in VSMCs is largely dependent upon Nox4 expression. Proinflammatory mediators down-regulated Nox4 but did not affect Nox1 expression, so other factors must compensate to regulate superoxide production.


1 Current address: Department of Pharmacology, Monash University, Victoria 3800, Australia. Tel.: +61 3 9905 4869; fax: +61 3 9905 5851.

Time for primary review 21 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Anilkumar, R. Weber, M. Zhang, A. Brewer, and A. M. Shah
Nox4 and Nox2 NADPH Oxidases Mediate Distinct Cellular Redox Signaling Responses to Agonist Stimulation
Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1347 - 1354.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
K. Bedard and K.-H. Krause
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Physiol Rev, January 1, 2007; 87(1): 245 - 313.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. E. Clempus, D. Sorescu, A. E. Dikalova, L. Pounkova, P. Jo, G. P. Sorescu, B. Lassegue, and K. K. Griendling
Nox4 Is Required for Maintenance of the Differentiated Vascular Smooth Muscle Cell Phenotype
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 42 - 48.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. J. Rickard, J. W. Funder, P. J. Fuller, and M. J. Young
The Role of the Glucocorticoid Receptor in Mineralocorticoid/Salt-Mediated Cardiac Fibrosis
Endocrinology, December 1, 2006; 147(12): 5901 - 5906.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Jiang, S. J. Roberts, S. r. Datla, and G. J. Dusting
NO Modulates NADPH Oxidase Function Via Heme Oxygenase-1 in Human Endothelial Cells
Hypertension, November 1, 2006; 48(5): 950 - 957.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. E. Clempus and K. K. Griendling
Reactive oxygen species signaling in vascular smooth muscle cells
Cardiovasc Res, July 15, 2006; 71(2): 216 - 225.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. P. Judkins, C. G. Sobey, T. T. Dang, A. A. Miller, G. J. Dusting, and G. R. Drummond
NADPH-Induced Contractions of Mouse Aorta Do Not Involve NADPH Oxidase: A Role for P2X Receptors
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 644 - 650.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. M. Piper and E. A. Martinson
Cardiovascular Research speeds up-Even more
Cardiovasc Res, March 1, 2006; 69(4): 773 - 776.
[Full Text] [PDF]


Home page
Circ. Res.Home page
A. A. Miller, G. R. Drummond, H. H.H.W. Schmidt, and C. G. Sobey
NADPH Oxidase Activity and Function Are Profoundly Greater in Cerebral Versus Systemic Arteries
Circ. Res., November 11, 2005; 97(10): 1055 - 1062.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Castier, R. P. Brandes, G. Leseche, A. Tedgui, and S. Lehoux
p47phox-Dependent NADPH Oxidase Regulates Flow-Induced Vascular Remodeling
Circ. Res., September 16, 2005; 97(6): 533 - 540.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Zalba, O. Beloqui, G. S. Jose, M. U. Moreno, A. Fortuno, and J. Diez
NADPH Oxidase-Dependent Superoxide Production Is Associated With Carotid Intima-Media Thickness in Subjects Free of Clinical Atherosclerotic Disease
Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1452 - 1457.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.